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We present a novel method for the directed evolution of
polypeptides,which combines in vitro compartmentalization
and covalent DNA display. A library of linear DNA
fragments is co-packaged with an in vitro transcription/
translation mixture in the compartments of a water-in-oil
emulsion. Experimental conditions are adjusted so that, in
most cases, one compartment contains one DNA molecule.
The DNA fragments encode fusion proteins containing a
DNA-methyltransferase (M.Hae III), which can form a
covalent bond with a 5-fluorodeoxycytidine base at the
extremity of the DNA fragment. The resulting library of
DNA–protein fusions is extracted from the emulsion and
DNA molecules displaying a protein with desired binding
properties are selected fromthepool ofDNA–protein fusions
by affinity panning on target antigens.Weapplied thismeth-
odology in model selection experiments, using specific
ligands for the capture of peptides and globular proteins
bound to DNA.We observed enrichment factors >1000-fold
for selections performed in separate emulsions and up to
150-fold for selections performed using mixtures of DNA
molecules. M.Hae III could be fused to small globular pro-
teins (such as calmodulin and fibronectin domains), which
are ideally suited for the generation of combinatorial librar-
ies and for the isolation of novel binding specificities.
Keywords: compartmentalization/covalent/DNA display/
in vitro/selection
Introduction
Protein-based recombinant biopharmaceuticals represent a
growing portion of the pharmaceutical market. By the end
of 2000, 84 recombinant biopharmaceuticals had gained mar-
keting authorization in the USA and/or the European Union for
use in humans (Walsh, 2000). Over the following 3 years, over
60 additional products have been approved and around 500 are
undergoing clinical evaluation (Walsh, 2003). Approximately
250 million people have benefited from these ‘biotech’ med-
icines and so has the business of biotechnology. The annual
global market for biopharmaceuticals is estimated at more than
$30 billion, compared with $12 billion just 3 years ago. These
numbers clearly indicate the potential benefit of therapeutic
proteins. The development of second generation protein drugs
with improved therapeutic characteristics such as potency, low
immunogenicity, good pharmacokinetics, high stability and
expression levels in simple production systems may require
the availability of advanced screening and selection methods
and improved computational algorithms for the design of
tailor-made proteins.
The ability to confer a desired binding specificity to a given
protein is of particular interest for pharmaceutical applications,
as suitable binding characteristics may improve relevant pro-
tein features such as pharmacokinetics, pharmacodynamics and
potency and allow a preferential accumulation of the protein at
sites of disease.
The engineering of the properties of a protein can be per-
formed by generating a large pool of protein mutants, followed
by the identification of those polypeptides which have acquired
the desired biological activity, as a consequence of the amino
acid mutations accumulated. With recombinant DNA techno-
logies, it is relatively straightforward to generate billions
of protein mutants; yet screening all the protein candidates
remains a formidable challenge, even in the presence of
sophisticated robotic equipment. As a consequence, a consid-
erable part of protein engineering research has focused on the
development of efficient selection methodologies, for the rapid
identification of proteins with desired characteristics (e.g. bind-
ing, catalysis, stability), out of very large pools of candidate
proteins.
All selection systems require a link between genotype
(a nucleic acid that can be replicated) and phenotype (a func-
tional trait such as binding or catalytic activity). This linkage is
usually achieved by physically linking genes to the proteins
they encode by a variety of techniques. They can be divided in
two classes, which (i) include living organisms in the selection
process, as is the case in phage display (Winter et al., 1994),
yeast surface display (Feldhaus et al., 2003) and bacterial sur-
face display (Olsen et al., 2000), or (ii) take place fully in vitro,
such as ribosome display (Mattheakis et al., 1994; Schaffitzel
et al., 1999), mRNA display (Roberts and Szostak, 1997), CIS
display (Odegrip et al., 2004), DNA display (Tabuchi et al.,
2001) and selection strategies involving in vitro compartmen-
talization (Tawfik and Griffiths, 1998; Sepp et al., 2002;
Griffiths and Tawfik, 2003) in combination with DNA display
(Doi and Yanagawa, 1999; Yonezawa et al., 2003).
The first class of selection methodologies involving live
organisms is well established and relatively robust. However,
all these methodologies require the transformation of living
cells with suitable plasmid DNA, a process which can be lab-
orious and limit library size. A further limiting factor may be
represented by the number of cells (or phage particles), which
can be used in practical selection procedures.
In order to circumvent the transformation of living cells,
research has been focused on the development of the second
class of selection strategies taking place fully in vitro, of which
ribosome display is a prominent example. However, the ternary
complex of mRNA, ribosome and displayed polypeptide is
stable only under certain conditions (high salt concentrations,
low temperatures), thus restricting the experimental conditions
in which selections can be performed. In addition, RNA is very
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sensitive to enzymatic contamination, which may lead to a
rapid degradation of the RNA.
We reasoned that an ideal in vitro system for the directed
evolution of proteins would comprise the following features:
(i) rapid generation of genetic diversity (library), (ii) facile and
irreversible linkage between phenotype (protein) and genotype
(genetic material), (iii) high expression levels of protein
mutants in the format used for the selection process, (iv) a
carrier of genetic information, which is stable under a wide
range of conditions (e.g. high and low salt concentrations,
extremes of temperature and pH, denaturing agents) and
(v) control of the number of proteins to be linked to the genetic
material (valence of display).
In this paper we propose a technology (Bertschinger and
Heinis, 2003) in which a library of linear DNA molecules is
co-packaged with an in vitro transcription/translation mix in
the compartments of a water-in-oil emulsion (Tawfik and
Griffiths, 1998) (Figure 1A and B). More than a decade ago
cell-free translation was achieved in reversed micelles of sur-
factants in organic solvents (Nametkin et al., 1992). A few
years later, Tawfik and Griffiths (1998) showed in their pio-
neering work that the composition of the organic phase of
emulsions could be adjusted to achieve stable, cell-like com-
partments for in vitro compartmentalization. Experimental
conditions are chosen so that, in most cases, one compart-
ment contains one DNA molecule (Figure 2A). A covalent
linkage between DNA and the encoded polypeptide is achieved
by using fusion proteins which contain the Hae III DNA-
methyltransferase domain of Haemophilus aegypticus, an
enzyme which is able to form a covalent bond with
DNA fragments containing the sequence 50-GGFC-30 (F =
5-fluoro-20-deoxycytidine) (Chen et al., 1991) (Figure 2B).
M.Hae III fusion proteins expressed in each compartment of
the water-in-oil emulsion are extracted from the emulsion. The
DNA molecules which display a protein with the desired bind-
ing specificity are selected from the pool of DNA–protein
fusions by affinity panning. The genetic information of the
selected DNA–protein fusions is amplified by polymerase
chain reaction (PCR) and can be used either for a further
round of selection or for cloning and characterization of the
selected mutants (Figure 1A).
Our experiments show that the ability of Hae III DNA-
methyltransferase to form a covalent complex with DNAmole-
cules containing the suicide inhibitor sequence 50-GGFC-30 can
be exploited to create a stable linkage between genotype
and phenotype in vitro. In model selection experiments,
DNA molecules were enriched on the basis of the protein
they encode from an excess of DNA molecules coding for a
protein with irrelevant binding specificity. Hae III DNA-
methyltransferase can be fused to small globular proteins
(such as calmodulin or fibronectin domains) which are devoid
of disulfide bridges and lend themselves to the generation of
combinatorial libraries for the isolation of specific binding
proteins (Smith, 1998).
Materials and methods
Preparation of water-in-oil emulsions and determination
of size distributions of the water compartments
Water-in-oil emulsions were essentially prepared as described
by Tawfik and Griffiths (1998). A 10-fold concentrated solu-
tion of oil phase was prepared by mixing 50% (v/v) mineral
oil (Sigma-Aldrich) with 45% (v/v) Span 80 (Fluka, Buchs,
Switzerland) and 5% (v/v) Tween 80 (Fluka). For the
Fig. 1. (A) Concept of the selection method. A library of linear DNA molecules is co-packaged with an in vitro transcription/translation mix into a water-in-oil
emulsion (1). Ideally, one compartment contains oneDNAmolecule. TheDNAmolecules each code for a Hae III DNA-methyltransferase fusion protein and contain a
mechanism-based inhibitor for the covalent cross-linking of the DNA-methyltransferase fusion proteins [see also (B) and Figure 2B]. After in vitro expression and
formation of the DNA–protein complexes, the water phase is extracted from the emulsion (2) and DNAmolecules displaying a protein with desired binding properties
are selected from the pool of DNA–protein fusions by affinity panning (3). The genetic information of selected DNA–protein fusions is amplified by PCR (4) and can
either be used for a further round of selection (5) or for cloning and characterization of the selectedmutants (6). (B) Enlarged viewof awater compartment of thewater-
in-oil emulsion. The DNA molecule is transcribed into mRNA, which is translated into a fusion protein consisting of two domains: the N-terminal Hae III DNA-
methyltransferase (yellow) and a C-terminal potential binding domain (red). Owing to the catalytic activity of the Hae III DNA-methyltransferase, the fusion proteins
form a covalent bond via the modified methylation target sequence 50-GGFC-30 (F = FdC = 5-fluorodeoxycytidine) with their encoding DNA molecule, which is
present in the same compartment of the water-in-oil emulsion.
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preparation of the emulsions, this concentrated stock solution
was diluted 10-fold in mineral oil and 950 ml were used for the
encapsulation of 50 ml of water phase. The mixing of the water
and the organic phases was done by the incremental addition of
5· 10 ml of ice-cooled water phase to ice-cooled oil phase in
a glass vial (Forma Vitrum, Switzerland, 40 · 18.75 mm).
Stirring was done at 2200 r.p.m. using a magnetic stirrer
(MR 1000, Heidolph, Germany) and a stirring bar (3 mm)
with a pivot ring. After addition of water phase, stirring was
continued for further 5 min to obtain the desired size distribu-
tion of the water compartments.
The size distributions of the water compartments were meas-
ured by laser diffraction using aMastersizer X (Malvern Instru-
ments, UK). A 30 ml volume of an emulsion was added to 10 ml
of mineral oil and mixed in the presentation cell of the
Mastersizer (30–40% stirring power). Particle size distribu-
tions were calculated with the instrument’s built-in Fraunhofer
optical model (Figure 3A) or Mie optical model (Figure 3B)
using refractive indices of 1.470 for mineral oil and 1.330 for
the aqueous phase.
Formation of covalent DNA–protein adducts
A 268 bp DNA fragment containing the suicide inhibitor
sequence 50-GGFC-30 for M.Hae III was used for the cross-
linking experiments. The modified nucleotide 5-fluorodeoxcy-
tidine was introduced by PCR amplification (T3 Thermocycler,
Biometra) of the DNA supplied in vial 3 of an RTS Escherichia
coli Linear Template Generation Set (Roche Applied Sciences)
using the synthetic oligonucleotides Hae sub fo (50-C GTC
ATG GFC TAT GCG GGC GAC CAC ACC CGT CCT
GTG GAT-30, modified substrate sequence in bold letters)
and Hae sub ba 1 (50-TAT TGC TAT GTA CCT AGC
GGG GGG GGT TCT CAT CAT CAT-30) (both oligonucleo-
tides from Microsynth, Switzerland). A 2 nM amount of DNA
was incubated with 38 nM M.Hae III (New England Biolabs,
USA) and 80 mM S-adenosylmethionine (New England Bio-
labs) in DNA-methyltransferase reaction buffer (50 mM NaCl,
50 mM Tris–HCl (pH 8.5), 10 mM dithiothreitol; New England
Biolabs). Cross-linking reactions were stopped by heat inac-
tivation (15 min at 70C). Samples were loaded on a denaturing
10% TBE urea polyacrylamide gel (Invitrogen) and DNA was
visualizedwithSYBRgreenII(MolecularProbes,USA).A10bp
DNA Ladder (Invitrogen) was used as a DNA marker.
Preparation of templates for in vitro transcription and
translation
The gene coding for Hae III DNA-methyltransferase was
ordered at ATCC (strain 11116). The DNA templates for
the expression of the various M.Hae III constructs were
assembled following the instructions of the RTS E.coli Linear
Template Generation Set (Roche Applied Sciences) with the
exception that the oligonucleotides Ext ba 2 (50-GAT GCC
GGC CAC GAT GCG TCC GGC GTA GAG-30, Qiagen)
and Ext 2 fo (50-GCT AAT TAG GFC ACC ACA CCC
GTC CT-30, modified substrate sequence in bold letters;
Microsynth, Switzerland) were used for the final PCR assembly
Fig. 2. (A) Schematic representation of DNA template used for the in vitro expression of M.Hae III fusion proteins. The sequences coding for Hae III DNA-
methyltransferase and the potential binding domain are flanked by T7 regulatory sequences (T7 promoter and T7 terminator) for efficient expression. The modified
base 5-FdC is introduced into the DNA by PCR at the downstream end of the DNA T7 terminator sequence. (B) Chemical reaction mechanisms that lead either to the
methylation of deoxycytidine (dC) (I) or to the covalent linkage ofM.Hae III with the modifiedmethylation sequence 50-GGFC-30 (F = FdC = 5-fluorodeoxycytidine)
(II). I:Methylation is initiated by nucleophile attack of an active site thiol group (Cys71) at C6 of cytosine. S-Adenosylmethionine (AdoMet) acts as themethyl donor.
The methylated dihydrocytosine intermediate undergoes beta-elimination to generate a 5-methylcytosine and an active enzyme. II: If the nucleotide
5-fluorodeoxycytidine is inserted in the methylation sequence (50-GGFC-30), the dihydrocytosine beta-elimination is blocked. The enzyme remains covalently
bound to the DNA substrate.
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instead of the primers supplied with the Linear Template
Generation Set. DNA was purified using a QIAquick Gel
extraction kit or QIAquick PCR purification kit (Qiagen). If
DNA was used directly for in vitro transcription/translation
reactions, DNA samples never were purified over an agarose
gel because agarose inhibits in vitro protein expression
(Manual RTS E.coli HY kit, Roche Applied Sciences).
Further details concerning the assembly of the different
M.Hae III fusions are as follows. M.Hae III-Flag tag: the
amino acid residues GGSG-DYKDDDK followed by two
stop codons were appended to the DNA-methyltransferase
gene in order to avoid the expression of the 6 · His tag,
which is included in the Linear Template Generation Set.
M.Hae III-EDB/CaM: the sequences coding for calmodulin
(CaM) and the extra-domain B of fibronectin (EDB) were
available in our laboratory. The amino acid residues GGSGAS
were used as linker for the C-terminal fusion of EDB/CaM to
M.Hae III. GST-M.Hae III: the M.Hae III gene was cloned as a
C-terminal fusion to glutathione-S-transferase (GST) in the
vector pGEX-4T-2 (Amersham Biosciences) using the restric-
tion sites BamHI and NotI (both enzymes from Promega). Both
genes were amplified together from the resulting vector and the
PCR product was used for PCR assembly using the Linear
Template Generation Set.
In vitro transcription/translation and western blot
All in vitro transcription/translation reactions were done using
the RTS 100 E.coli HY kit (Roche Applied Sciences). In order
to allow the formation of covalent DNA–protein adducts, 80mM
S-adenoslymethionine was added to the transcription/transla-
tion mix. For western blot analysis, 2 ml of the transcription/
translation mixtures (non-emulsified expression) were loaded
on a 10% Bis-Tris SDS–polyacrylamide gel [Invitrogen, pro-
tein marker RPN 800 (Amersham Biosciences)] followed by
blotting on a PVDF membrane (0.45 mm pores, Immobilon
Transfer Membrane, Millipore), which was previously
activated by soaking for 15 s in 100% methanol followed
by 2 min in water. After blotting, the PVDF membrane was
quickly rinsed with water, soaked for 2 · 15 s in methanol
and then air-dried on a filter-paper. M.Hae III fusion proteins
bearing a 6 · His tag were detected using an anti-His-HRP
immunoconjugate (Sigma-Aldrich). M.Hae III-Flag tag protein
was detected using anti-Flag tag (M2) as primary antibody
(Sigma-Aldrich) and anti-mouse-HRP immunoconjugate as
secondary antibody (Sigma-Aldrich). The PVDF membrane
was incubated with the antibodies for 45 min at room temper-
ature in 3% milk PBS (shaking at 65 r.p.m.). Subsequently, the
membrane was washed four times with PBS. HRP activity was
detected with the ECL kit (Amersham Biosciences) as indi-
cated by the manufacturer.
Model selection experiments
In vitro transcription/translation mix (TS/TL-mix) was pre-
pared on ice according to the instructions of the manufacturer
of the kit (RTS 100 E.coli HY kit, Roche Applied Sciences). A
40 ml volume of the TS/TL-mix, 5 ml of S-adenosylmethionine
(stock, 800 mM; final concentration, 80 mM), DNA and 5 ml of
water were mixed in order to obtain a final volume of 50 ml.
DNA was added just before preparing the emulsion. A 50 ml
volume of ice-cooled water phase (in vitro TS/TL-mix contain-
ing the DNA template) was added to 950 ml of oil phase (ice-
cold) in a stepwise manner (5 · 10 ml during 2 min) whilst
stirring at 2200 r.p.m. in a glass vial. After stirring, the emul-
sion was transferred to a 1.5 ml microcentrifuge tube.
Proteins were expressed in emulsion by incubation for
150 min in a heat block at 30C. After protein expression
and formation of the covalent DNA–protein adducts, emulsions
were broken by centrifugation for 10 min at 7000 r.p.m. in a
table-top centrifuge (Eppendorf). Water droplets formed a pel-
let and the organic supernatant was removed. A 150 ml volume
of room temperature breaking buffer was added [PBS (or
TBS with 1 mM CaCl2 for selections with calmodulin
(TBSC)], pH 7.4, 5 mM biotinylated ds DNA fragments
[50-biotin-GGA GCT TCT GCA TTC TGT GTG CTG-30
(Qiagen)], 1 mM competing ds DNA fragments [50-ATC
TAA GGC CAA TGT ACT AGA CGG CCA TTC CAG
ATG CAG GCC AAG CGT ACA TAC GGC CTA GCT
AAA TCA AGG CCG TAT CGT-30, substrate recognition
sites of M.Hae III in bold letters, (Qiagen)] followed by 1 ml
of room temperature diethyl ether (water saturated). The tube
Fig. 3. (A) Reproducibility of emulsion preparation: three emulsions were independently prepared as described above (curves 1, 2 and 3). The size distributions were
very similar. (B) Stability ofwater-in-oil emulsions: an emulsionwas prepared and size distributions ofwater compartmentsweremeasured after storage for 0 h (1) and
96 h (2) at room temperature, respectively.
J.Bertschinger and D.Neri
702
was vortexed at full speed for 2 · 10 s. After separation of
the water phase and the organic phase, the water phase was
removed from the bottom of the tube and transferred to a
24-well plate (NUNCLON Surface, Nunc). The extracted
water phase was air-dried at room temperature for 10 min
until residual Et2O was completely evaporated.
Volumes of 25–50 ml of magnetic streptavidin-coated Dyna-
beads (Dynal, Norway) were incubated for 15 min with the
capture agent at room temperature fbiotinylated anti-penta-His
antibody (4 ml or 800 ng/50 ml beads) (Qiagen), biotinylated
anti-Flag antibody (M2, 2 ml or 2 mg/50 ml beads) (Sigma-
Aldrich), biotinylated anti-EDB antibody (5 ml/50 ml beads,
200 nM) [L19 small immunoprotein (Li et al., 1997), which
was kindly provided by P.Alessi, Institute of Pharmaceutical
Sciences, ETH Zurich, Switzerland], biotinylated calmodulin
binding peptide [biotin-CAAARWKKAFIAVSAANRFKKIS
(Montigiani et al., 1996), which was kindly provided by
L.Lozzi, Dipartimento di Biologia Molecolare, Universita’
di Siena, Italy] (4 ml/50 ml beads, 800 nM)}. The beads
were washed once with PBS 0.1% Tween 20 (PBST) or
TBSC 0.1% Tween 20 (TBSCT) (if CaM-binding peptide
was used as capture agent) and blocked with 5 mM biotinylated
ds DNA fragments [50-biotin-GGA GCT TCT GCA TTC TGT
GTG CTG-30 (Qiagen)] for 15 min at room temperature. The
beads were then incubated with the extracted water phase for
45 min at room temperature. The samples were shaken gently
from time to time. The magnetic beads were washed six times
with 100 ml of PBST or TBSCT, followed by one wash with
100 ml of PBS or TBSC using a magnetic separator (Dynal,
Norway). The beads were resuspended in 100 ml of water and
used directly for PCR amplification of the DNA molecules
remaining on the beads using the primers Ampl ba (50-CCC
GCG AAA TTA ATA CGA CTC A-30, Qiagen) and Ampl fo
(50-AAA ACC CCT CAA GAC CCG TT-30, Qiagen). As an
exception, PCRs for Figure 6 were done using the primers
M.Hae Nco ba (50-GGA GAT ATA ACC ATG GGC AAT
TTA ATT AGT CTT TTT TCA GGT-30, Qiagen) and
M.Hae Xho His fo (50-TAT AGC TCG CTC GAG ATT
ACC TTT ACA AAT TTC CAA TGC AGA-30, Qiagen).
Smart Ladder (Eurogentec) was used as a DNA marker on
the agarose gel (Figure 6).
Real-time PCR
An ABI PRISM 7000 instrument (Applied Biosystems), ABI
PRISM 96-well Optical Reaction Plates with MiniAmp Optical
Caps (Applied Biosystems) and TaqMan Universal PCR
Master Mix (Applied Biosystems) were used for all real-
time PCR measurements. All reactions were done in triplicate
for each sample. Primers and TaqMan probes were designed
with Primer Express 1.5 software (Applied Biosystems). Pri-
mers were used at a concentration of 200 nM and the TaqMan
probe at 100 nM. DNA samples were diluted in such a way that
the expected number of molecules detected by real-time PCR
was between 102 and 106.
Results
Preparation of water-in-oil emulsions and determination
of size distribution of the water compartments
A basic requirement for the proposed methodology is the
ability to produce a water-in-oil emulsion with individual
compartments, whose size and stability (no fusion with other
compartments) can be controlled. The water-in-oil emulsions
were prepared by stirring a mixture of oil phase and water
phase. The latter contained the DNA template and an in vitro
transcription/translation mix. The time and the velocity of stir-
ring are critical parameters for the shape of the size distribution
of the water compartments of the water-in-oil emulsion. Water-
in-oil emulsions were prepared as described in the literature
(Tawfik and Griffiths, 1998) with minor modifications and the
size distribution of the water compartments of the emulsions
was determined by laser diffraction. Three emulsions were
prepared independently and the corresponding size distribu-
tions were measured (Figure 3A). The average diameter of
the water compartments was about 1 mm with 67.5%
(63.5% s.d., n = 3) of the water volume being in compartments
with diameters ranging from 0.71 to 1.84 mm (area under
the curve).
In order to determine the stability of the water-in-oil emul-
sions, we checked whether the size distribution of the water
compartments changed over time. One emulsion was prepared
and the size distribution of the water compartments was deter-
mined immediately using only a small amount of the emulsion.
The remaining part of the emulsion was left for 96 h at
room temperature until the second measurement was per-
formed (Figure 3B). The profiles of the two curves obtained
at the different time points did not differ significantly from
each other, indicating a remarkable stability of the water-in-oil
emulsions.
Formation of covalent protein–DNA adducts
We showed that M.Hae III can be linked covalently to DNA
fragments which contain the modified substrate sequence for
the DNA-methyltransferase (50-GGFC-30) by incubating DNA
(2 nM), S-adenosylmethionine (SAM, 80 mM) and M.Hae III
(38 nM) for different time periods (Chen et al., 1991). The
concentrations of the reactants were chosen to be in the low
nanomolar range in order to mimic the conditions for cross-
linking DNA with protein, assuming that one DNA molecule
with about 15 molecules of M.Hae III are present in one com-
partment of a water-in-oil emulsion after transcription and
translation. Reactions were stopped by heat inactivation of
the DNA-methyltransferase (15 min at 70C) and the outcome
of the experiment was analysed on a denaturing TBE gel
containing 8 M urea (Figure 4). The heating step and the
Fig. 4. Covalent coupling ofM.Hae III with a 268 bpDNA fragment containing
themodifiedmethylation site 50-GGFC-30. DNA (2 nM),M.Hae III (38 nM) and
S-adenosylmethionine were incubated at 37C for different time periods (given
in minutes above the gel). M.Hae III was inactivated by heating (70C, 15 min)
and the samples were loaded on a denaturing polyacrylamide gel (10%, 8 M
urea) and DNA was stained with SYBR green II. DNA molecules covalently
bound to M.Hae III are shifted upwards as compared with free DNA (indicated
in the figure). Three controls are shown on the right: 1, without
S-adenosylmethionine; 2, without M.Hae III; 3, only 268 bp DNA fragment;
M, 10 bp marker.
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denaturing conditions during gel electrophoresis should allow
the disruption of all non-covalent protein–DNA complexes.
After a reaction time of 120 min, about 50% of the DNA
molecules were covalently associated with one protein of
M.Hae III DNA-methyltransferase. The yield of DNA–protein
adducts did not increase if the reaction was allowed to
proceed for up to 240 min. If DNA containing the suicide
inhibitor and Hae III DNA-methyltransferase were incubated
without the cofactor SAM, no covalent protein–DNA adducts
were detected. This result is in accordance with the
reaction mechanism described in the literature (Figure 2B)
(Chen et al., 1991).
In vitro expression of M.Hae III–polypeptide fusions
A further important requirement for a selection methodology
is the possibility of expressing a variety of different poly-
peptides in the format needed for the selection process.
Therefore, we examined different M.Hae III fusion proteins
for their expression levels in vitro. Five DNA templates were
assembled by PCR coding for M.Hae III-6 · His tag, M.Hae
III-Flag tag, M.Hae III-CaM-6 · His (calmodulin), M.Hae
III-EDB-6 · His (extra-domain B of fibronectin) and GST-
M.Hae III-6 · His (glutathione-S-transferase of Schistosoma
japonicum). All polypeptides except GST were C-terminal
fusions to M.Hae III.
Each M.Hae III fusion protein was expressed using 200–
250 ng of DNA template in a volume of 25 ml of in vitro
transcription/translation mixture and, after incubation at
30C for 3.5 h, the expression levels of the fusion proteins
were analysed by western blotting. Proteins were detected
using either anti-His tag–horseradish peroxidase (HRP)
immunoconjugate (for M.Hae III-6 · His tag, -CaM-6 ·
His tag, -EDB-6 · His tag and GST-M.Hae III-6 · His tag)
or anti-Flag antibody (M2) in combination with a secondary
anti-mouse-HRP detection reagent (for M.Hae III-Flag tag)
(Figure 5). All constructs except GST-M.Hae III-6 · His
were well expressed and appeared to have the correct size,
without any detectable proteolytic fragments. The fusion pro-
teins also were catalytically active, as shown by the ability of
the fusion proteins to protect DNA fragments from digestion
with the restriction nuclease NotI (data not shown). The
expression yield for M.Hae III-6 · His tag was estimated from
signal intensities on western blots to be about 300 ng/ml
in vitro transcription/translation mixture (data not shown).
Expression of M.Hae III fusion proteins was markedly
lower (20%) compared with expression yields obtained in
bulk solution (data not shown).
Model affinity selections with DNA templates coding for
M.Hae III-6 · His or -Flag fusion proteins
In order to test the practical feasibility of covalent DNA display
methodology, we performed experiments using two peptides
(6 · His and Flag tag) as M.Hae III fusion and two specific
monoclonal antibodies for affinity capture. Amounts of 100 ng
of DNA molecules coding either for M.Hae III-6 · His tag or
M.Hae III-Flag tag protein were emulsified separately. After
protein expression at 30C for 2.5 h, the two emulsions were
centrifuged for 10 min at 10 000 r.p.m.. The oil supernatants
were removed and the water phases, containing the protein–
DNA adducts, were extracted from the pellets formed by the
still intact water compartments at the bottom of the tubes by
addition of diethyl ether. Subsequently, the extracted water
phases were dried to remove residual traces of diethyl ether
and divided into two halves each. The first two halves of the
water phases containing DNA-M.Hae III-6 · His or DNA-
M.Hae III-Flag adducts were used for affinity pannings with
biotinylated anti-penta-His and the second two halves were
taken for pannings with biotinylated anti-Flag antibody immo-
bilized on magnetic streptavidin beads. DNA molecules still
bound to the beads after washing were amplified by PCR
(amplicon length = 1020 bp) without prior elution from the
magnetic beads. The outcome of the selections was analysed on
an agarose gel (Figure 6). As expected, only DNA coding for
M.Hae III-6 · His was selected if the affinity capture was
performed with anti-penta-His antibody, whereas DNA coding
Fig. 5. In vitro expression of M.Hae III fusion proteins. Linear DNA templates
coding for different M.Hae III fusion proteins were incubated in an in vitro
transcription/translation mix. A 2 ml volume was taken for western blot analysis
[detection: anti-His-HRP or anti-Flag (M2)/anti-mouse-HRP]. M, marker; 1,
M.Hae III-6 ·His tag (total molecular weight, 38 kDa); 2, M.Hae-calmodulin-6
· His (56 kDa); 3, M.Hae III-ED-B-6 · His (extra-domain B of fibronectin)
(49 kDa); 4, GST-M.Hae III-6 · His tag (S.japonicum) (64 kDa); 5, M.Hae III-
Flag tag (38 kDa); +, 1.5 mg recombinantly expressed M.Hae III-6 · His tag
(38 kDa); –, transcription/translation mix. All peptides/proteins except GST
were C-terminal fusions to M.Hae III.
Fig. 6. Model selections: 100 ng linear DNA templates (6.6 · 1010 molecules)
coding for either M.Hae III-6 · His tag or M.Hae III-Flag tag were emulsified
with 50 ml of in vitro transcription/translation mixture. Covalent protein–DNA
adducts were extracted from the emulsions after expression for 2 h at 30C.
Affinity panning experiments were done with magnetic streptavidin beads
coated either with biotinylated anti-His or anti-Flag (M2) antibody. In order to
amplify the selected DNAmolecules, PCR was performed directly on the beads
afterwashing. PCRproducts (1020 bp long)were loaded on an agarose gel. His=
DNAcoding forM.Hae III-6·His tag used for selection; Flag=DNAcoding for
M.Hae III-Flag tag used for selection.Affinity panningwith anti-His antibody or
anti-Flag antibody as indicated below the agarose gel. M, DNA marker.
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for M.Hae III-Flag tag could not be detected. However, if anti-
Flag antibody was used for affinity selection, only DNA coding
for M.Hae III-Flag was recovered and detected on the agarose
gel after PCR. Therefore, we concluded that it is possible to
select DNA molecules via the binding specificity of the
encoded protein.
Quantification of selection efficiency
For the measurement of the efficiency with which DNA–
protein adducts were selected by virtue of their binding affinity
to the immobilized antibody on the magnetic beads, model
selection experiments were performed as described above
using additional M.Hae III fusion constructs. The number of
DNA molecules recovered was determined by real-time PCR
using a TaqMan probe specific for the DNA-methyltransferase
gene. In a first set of experiments (Table I, upper half), two
emulsions were prepared, one of which contained DNA coding
for M.Hae III-6 · His and the other DNA encoding M.Hae III-
Flag. After protein expression and extraction of the water
phases, affinity selections using magnetic streptavidin beads
coated with biotinylated anti-Flag antibody were performed. In
Table I, the number of DNA molecules used as input for the
selections and the corresponding outputs are given. The data
show that DNA-M.Hae III-Flag adducts were selected 1000
times more efficiently than an irrelevant DNA–protein adduct
(in this case M.Hae III-6 · His).
In a second set of experiments, various M.Hae III constructs
were separately expressed in emulsion and, after extraction from
the emulsion, affinity selectionswere performed usingmagnetic
streptavidin beads coated with specific or irrelevant antibody. If
the streptavidin beads were coated with specific antibody/pep-
tide,DNAmoleculeswere recoveredmuchmore efficiently than
compared to the control selection, in which an irrelevant anti-
body was immobilized on the beads (Table I, lower half).
Model selections with DNA mixtures
For practical applications, the covalent DNA display methodo-
logy will be preferentially used for the selection of globular
proteins of desired binding specificities. In the ideal case, such
proteins are devoid of disulfide bonds, are stably folded and are
well expressed in bacteria. Calmodulin (Neri et al., 1995;
Montigiani et al., 1996) and a number of fibronectin domains
(Zardi et al., 1987; Xu et al., 2002) fulfil these requirements.
Mixtures of DNA templates coding either for M.Hae III-CaM
or M.Hae III-EDB were prepared in such a way that the ratio of
M.Hae III-EDB/-CaM DNA molecules was 1000 and that
109–1010 DNA molecules were used per selection experiment.
Biotinylated CaM-binding peptide was used to coat the mag-
netic beads in order to enrich DNA coding for M.Hae III-CaM
from these DNA mixtures, whereas biotinylated anti-Flag
antibody served as a negative control because neither of the
two proteins contained a Flag-tag and, therefore, the ratio of
M.Hae III-EDB/-CaM DNA molecules should not change as
compared with the input ratio. DNA molecules recovered from
the selection process were amplified by PCR. Selection experi-
ments were analysed by real-time PCR using TaqMan probes
specific for either M.Hae III-EDB or -CaM DNA. The ratio of
M.Hae III-EDB/-CaM DNA molecules was determined before
selection (input) and after selection with CaM-binding peptide
or anti-Flag antibody (Table II). In the last column of Table II,
enrichment factors were calculated by dividing the value of the
input ratio by the value of the output ratio (using CaM-binding
peptide as capture agent). The DNA mixtures, obtained from
PCR amplification of recovered DNA molecules on the mag-
netic beads, were diluted 1:104–105 for real-time PCR analysis.
Using 1010 DNA molecules as input for the selection pro-
cedure, enrichment factors ranged between 42 and 94 (Table II,
selection experiments 1–7). If only 109 DNA molecules were
used, enrichment factors increased to 81–153 (Table II, selec-
tion experiments 8–10). In some control selections with the
irrelevant anti-Flag antibody, DNA coding for M.Hae III-CaM
was not detectable by real-time PCR, having been diluted out
during the washing steps.
Discussion
We propose an in vitro selection system in which phenotype
(protein) and genotype (DNA) are physically linked by a
Table I. Affinity selections with different M.Hae III fusion constructs
M.Hae III construct Input Capture agent Outputa (6s.d.b) Ratioc
M.Hae III-Flag tag 6 · 1010 anti-Flag ab 2.3 6 0.2 · 106
M.Hae III-6 · His 6 · 1010 7.6 6 2.0 · 102 3026
M.Hae III-Flag tag 6 · 1010 anti-Flag ab 4.0 6 0.5 · 105
M.Hae III-6 · His 6 · 1010 5.0 6 0.8 · 102 800
M.Hae III-Flag tag 6 · 1010 anti-Flag ab 1.7 6 0.1 · 106
M.Hae III-6 · His 6 · 1010 5.5 6 1.4 · 102 3091
M.Hae III-Flag tag 6 · 1010 anti-Flag ab 1.9 6 0.2 · 106
M.Hae III-6 · His 6 · 1010 5.2 6 1.6 · 102 3654
M.Hae III-6 · His 3 · 1010 anti-His ab 4.4 6 0.3 · 105
3 · 1010 anti-Flag ab 7.9 6 3.6 · 102 557
M.Hae III-6 · His 1 · 1010 anti-His ab 2.0 6 0.1 · 106
1 · 1010 anti-Flag ab 2.9 6 0.9 · 102 6897
M.Hae III-EDB 5 · 1010 anti-EDB ab (L19) 1.3 6 0.1 · 106
5 · 1010 anti-Flag ab 4.0 6 0.2 · 102 3250
M.Hae III-CaM 5 · 1010 CaM-pep 2.9 6 0.2 · 105
5 · 1010 anti-Flag ab 1.7 6 0.6 · 102 1076
M.Hae III-CaM 5 · 1010 CaM-pep 7.8 6 1.1 · 105
5 · 1010 anti-Flag 6.9 6 1.4 · 102 1130
aOutput values were measured by real-time PCR using 0.1% of the beads after washing.
bStandard deviation: all measurements were performed in triplicate.
cRatio of the two corresponding output values.
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covalent bond. This physical linkage between a protein and its
encoding DNA molecule was created by exploiting the ability
of Hae III DNA-methyltransferase of H.aegypticus to form
a covalent bond with DNA fragments containing the sequence
50-GGFC-30 (F = 5-fluorodeoxycytidine) (Chen et al., 1991).
DNA molecules coding for M.Hae III-CaM proteins were
successfully and reproducibly selected in model selection
experiments from a more than 1000-fold excess of DNA mole-
cules coding for M.Hae III-EDB.
As shown in Table I, the efficiency of DNA recovery from
affinity selections varied by more than three orders of magni-
tude, depending on the binding specificity of the polypeptide
used as capture agent. These results imply that DNA molecules
coding for a protein with appropriate binding characteristics
could be enriched from a mixture of different DNA molecules
by a factor of 1000. However, enrichment factors obtained
from model selection experiments starting from mixtures of
two different DNA templates were lower than expected by a
factor of 10–20 (Table II). These findings may be explained by
different reasons.
First, more than one DNA molecule might be present in one
water compartment of the water-in-oil emulsion, which would
lead to the incorrect assignment of genotype and phenotype
and, therefore, to the selection of DNA molecules coding for
non-binding proteins. This could explain why enrichment fac-
tors increased by almost a factor of three if 109 instead of 1010
DNA molecules were used as input for the selection experi-
ments. With the mean diameter of a water compartment of the
emulsion being1 mm (Figure 3) and given that 50 ml of water
phase are encapsulated in 950 ml of oil phase, there should be
roughly 1011 distinct water compartments in the resulting
emulsion. However, this calculation contradicts the results
obtained from selections with 1010 and 109 DNA molecules.
If 1011 water compartments were formed in 1 ml of emulsion
and 1010 DNA molecules were used as input, there would be
only 0.1 DNA molecule on average per water compartment.
Therefore, one would not expect the enrichment factors to
improve if the starting amount of DNA molecules is lowered
by a factor of 10. However, enrichment factors improved by
decreasing the amount of DNA molecules in the selection and,
therefore, the size distributions might be shifted to larger mean
diameters (Figure 3), as described previously (Tawfik and
Griffiths, 1998). It should be noted that emulsions had to be
diluted in mineral oil before size distributions were measured
(see Materials and methods), which could influence the com-
partment size.
Second, fusion of compartments followed by fission taking
place during protein expression and formation of DNA–protein
adducts could lead to the exchange of the contents between
different water compartments without changing the profile of
the size distributions.
For the two reasons described above, it would be desirable to
test various ways of encapsulation techniques in order to obtain
even smaller water compartments, which might be more stable.
Third, after extraction of the water phase from the emulsion,
free M.Hae III fusion proteins, which are not linked to their
encoding DNA molecule, might bind to other DNA molecules
in a non-covalent manner and, therefore, lead to the selection of
DNA molecules coding for non-binding proteins. Hae III
DNA-methyltransferase binds its substrate sequence
50-GGCC-30 with nanomolar affinity (Chen et al., 1993). In
order to capture free M.Hae III fusion proteins, short DNAT
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fragments (1 mM) containing five times the DNA-methyltrans-
ferase substrate sequence 50-GGCC-30 were added during
extraction to the water phase. However, the high affinity of
M.Hae III for its substrate sequence is advantageous and a
prerequisite for a fast and efficient cross-linking reaction be-
cause one DNA molecule in a water compartment with a dia-
meter of 1 mm corresponds to a concentration of 3 nM.
Different fusion constructs of Hae III DNA-methyltransferase
were expressed in vitro with high yields and without signs of
proteolysis (Figure 5), which promotes M.Hae III as a good
fusion partner for many different proteins.
The results obtained by model selection experiments indic-
ate the robustness and efficiency of this selection system, which
may be useful for the directed evolution of peptides and small
globular proteins for the generation of novel protein therapeu-
tics and bioseparation reagents (Tomlinson, 2004). Owing to
the covalent link between protein and DNA, this selection
methodology could be especially well suited for the engineer-
ing of proteins which are required to be stable under harsh
conditions, such as high temperatures, presence of denaturing
agents, extremes of pH, high or low salt concentrations and
organic solvents. Such proteins could find various applications
in many different fields of industrial biotechnology and nano-
technology.
Recently, the work of two other groups has been published in
the field of DNA display. The first group used the strong non-
covalent interaction of the biotin-streptavidin complex to cou-
ple proteins with DNA (Yonezawa et al., 2003). A biotinylated
DNA library coding for random decapeptides fused to strepta-
vidin was expressed in the water compartments of a water-in-
oil emulsion and peptides binding to anti-Flag antibody were
successfully selected from the resulting library of DNA–
protein complexes. The strength of the interaction between
biotin and streptavidin is advantageous. However, in a previous
study by the same group (Doi and Yanagawa, 1999), only 1%
of input DNA associated with peptides, probably owing to low
yields of streptavidin-fused peptides expressed in an E.coli S30
in vitro transcription/translation system. The situation could
be improved by using a wheat germ in vitro transcription/
translation system leading to the formation of DNA–
peptide conjugates with an efficiency of >95%. It remains to
be seen whether streptavidin fused to larger proteins can also be
expressed with sufficiently high yields.
The second group (Odegrip et al., 2004) presented an
alternative DNA-based approach which does not require en-
capsulation for correct assigment of proteins with their encod-
ing DNA molecules. This is possible due to the cis-acting
activity of RepA protein, which binds with high fidelity to
its encoding DNA molecule. However, the interaction of
RepA with its binding site on DNA is neither covalent nor
as strong as that of biotin with streptavidin, which may impair
the selection of binding proteins with slow dissociation
kinetics (low koff).
With the approach presented here, a combination of a very
stable physical linkage and high expression levels of different
fusion proteins was achieved. In addition, the number of M.Hae
III fusion proteins linked per DNA molecules might be varied
by simply adjusting the number of M.Hae III substrate
sequences containing the modified base 5-fluorodeoxycytidine
in the DNAmolecule. Covalent complexes of a DNA gene with
a defined, small number of copies of the encoded protein could
also reduce the bias in selection due to different expression
levels. Coupling proteins covalently to DNA is potentially not
only useful for selection of binding activity, but DNA–protein
fusions could also be re-compartmentalized in emulsions and
selected for catalysis (Griffiths and Tawfik, 2003). In addition,
more complex selection protocols for the engineering of allo-
steric proteins could also be applied more easily owing to the
covalent nature of the linkage between protein and DNA.
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